Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Pruritus? 1,080 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,080 reports of Pruritus have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 2.8% of all adverse event reports for CABOZANTINIB S-MALATE.

1,080
Reports of Pruritus with CABOZANTINIB S-MALATE
2.8%
of all CABOZANTINIB S-MALATE reports
31
Deaths
142
Hospitalizations

How Dangerous Is Pruritus From CABOZANTINIB S-MALATE?

Of the 1,080 reports, 31 (2.9%) resulted in death, 142 (13.1%) required hospitalization, and 1 (0.1%) were considered life-threatening.

Is Pruritus Listed in the Official Label?

Yes, Pruritus is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Pruritus?

DUPILUMAB (44,279) ADAPALENE (12,072) ADALIMUMAB (9,644) AVOBENZONE\OCTISALATE\OCTOCRYLENE (9,439) SECUKINUMAB (8,755) ETANERCEPT (8,047) METHOTREXATE (7,526) LENALIDOMIDE (6,304) TOCILIZUMAB (5,973) RITUXIMAB (5,548)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Pruritus Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Pruritus Reports All Drugs Causing Pruritus CABOZANTINIB S-MALATE Demographics